| Literature DB >> 34907423 |
Bo Liu1, Qingfeng Zhang2, Jingou Wang1, Shumin Cao1, Zhiyuan Zhou1, Ze-Xian Liu2, Han Cheng1.
Abstract
To date, various studies have found that the occurrence of cancer may be related to viral infections. Therefore, it is important to explore the relationship between viruses and diseases. The International Agency for Research on Cancer has defined six types of viruses as Class 1 human carcinogens, including Epstein-Barr virus, hepatitis C virus, hepatitis B virus, human T-cell lymphotropic virus, human herpesvirus 8 and human papillomavirus, while Merkel cell polyomavirus is classified as 'probably carcinogenic to humans' (Group 2A). Therefore, in-depth research on these viruses will help clarify their relationship with diseases, and substantial efforts have been made to sequence their genomes. However, there is no complete database documenting these cancer-associated viruses, and researchers are not able to easily access and retrieve the published genomes. In this study, we developed iCAV, a database that integrates the genomes of cancer-related viruses and the corresponding phenotypes. We collected a total of 18 649 genome sequences from seven human disease-related viruses, and each virus was further classified by the associated disease, sample and country. iCAV is a comprehensive resource of cancer-associated viruses that provides browse and download functions for viral genomes. Database URL: http://icav.omicsbio.info/.Entities:
Mesh:
Year: 2021 PMID: 34907423 PMCID: PMC8725190 DOI: 10.1093/database/baab079
Source DB: PubMed Journal: Database (Oxford) ISSN: 1758-0463 Impact factor: 3.451
The keywords and length range of each virus
| Virus | Keywords | Length |
|---|---|---|
| HTLV | Human T-cell lymphotropic virus OR HTLV OR Human T-lymphotropic virus | 8000–10 000 |
| HBV | Hepatitis B virus OR HBV | 3000–3300 |
| HCV | Hepacivirus C OR HCV | 8900–10 000 |
| MCV | Merkel cell polyomavirus OR MCV OR MCPyV | 5000–5500 |
| HPV | Human papillomavirus OR HPV | 7000–10 000 |
| HHV-8 | Human gammaherpesvirus 8 KSHV Kaposi’s sarcoma- associated herpesvirus | 130 000–140 000 |
| EBV | Human herpesvirus 4 OR Human gamma- herpesvirus 4 OR EBV OR Epstein–Barr virus | 160 000–180 000 |
Figure 1.Relationships among samples, viruses and diseases. This figure shows mainly samples and diseases.
The phenotypes of each virus
| Virus | Phenotypes | Count |
|---|---|---|
| HBV | CHB | 3652 |
| Health | 2575 | |
| Hepatitis | 462 | |
| HCC | 175 | |
| Other diseases | 2349 | |
| HPV | CC | 196 |
| SCC | 19 | |
| GC | 1 | |
| Health | 433 | |
| Other diseases | 5973 | |
| HCV | Hepatitis | 50 |
| Chronic hepatitis C (CHC) | 45 | |
| HCC | 41 | |
| Health | 794 | |
| Other diseases | 436 | |
| EBV | Nasopharyngeal cancer | 283 |
| Natural-killer/T cell lymphoma (NKTCL) | 53 | |
| GC | 26 | |
| Hodgkin lymphoma | 16 | |
| Lung cancer (LC) | 4 | |
| Health | 213 | |
| HTLV | HTLV-1-associated myelopathy/tropical spastic palsy | 78 |
| Health | 59 | |
| Adult T-cell leukemia-lymphoma (ATLL) | 16 | |
| Other diseases | 51 | |
| HHV8 | Kaposi’s sarcoma (KS) | 19 |
| Primary effusion lymphoma (PEL) | 3 | |
| Multicentric castleman disease (MCD) | 3 | |
| Other diseases | 50 | |
| MCV | MCC | 28 |
| Other diseases | 5 | |
| Health | 33 |
The samples of each virus
| Virus | Samples | Count |
|---|---|---|
| HBV | Serum | 5410 |
| Blood | 119 | |
| Plasma | 772 | |
| Biopsy | 12 | |
| Other samples | 2892 | |
| HPV | Biopsy | 160 |
| Other samples | 6372 | |
| Cervical swab | 78 | |
| Serum | 12 | |
| HCV | Plasma | 677 |
| Serum | 434 | |
| Cell lines | 10 | |
| Other samples | 245 | |
| EBV | Saliva | 291 |
| Other samples | 371 | |
| Biopsy | 284 | |
| Plasma | 1 | |
| Cell line | 156 | |
| HTLV | Peripheral blood mononuclear cell (PBMC) | 106 |
| Other samples | 52 | |
| Blood | 45 | |
| Plasma | 1 | |
| HHV8 | Other samples | 56 |
| Biopsy | 16 | |
| Cell line | 3 | |
| MCV | Other samples | 54 |
| PBMC | 5 | |
| Biopsy | 5 | |
| Cell line | 1 | |
| Serum | 1 |
Figure 2.The usage of iCAV. (A–E) Five steps to use iCAV.